v3 Template
H

HemostOD

Biotechnology ~50 employees
Founded
--
Employees (Est.)
~50
5 leaders known
Total Funding
$6.8M
Funding Rounds
2
Last Funding
2026-02-03

About HemostOD

HemostOD is a Swiss-based preclinical biotech company founded in 2020, located at the EPFL Innovation Park in Lausanne, Switzerland. The company focuses on engineering and manufacturing universal platelets using a proprietary platform to address critical medical needs and save lives through innovative platelet biology applications.

Products & Services

Thrombocytopenia Treatment:Developing universal platelets for patients with or at risk of HLA immune-refractoriness.
Tissue-Targeted Cargo Delivery (CAR-PLT):Using CAR-PLT technology for shielded delivery of miRNA/siRNA or proteins to specific target tissues.
Regenerative Medicine:Utilizing engineered platelets for wound healing, anti-inflammatory, and immunomodulating applications.
Culture of Therapeutic Stem Cells:Using platelet lysate from universal platelets to enhance cell proliferation.

Specialties

Platelet Engineering Platelet Manufacturing Thrombocytopenia Treatment Tissue-Targeted Cargo Delivery Regenerative Medicine Stem Cell Culture Molecular & Cell Biology Advanced Microfluidic Technologies

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Grant
T: -
FT: Grant 		A: 2500000
MR: -
FA: CHF 2 million
FAN: 2500000 		D: 2026-02-03
FD: 2026-02-03 		1 investors
2 RT: Seed Extension
T: -
FT: Seed Extension 		A: 4300000
MR: -
FA: CHF 4.3 million
FAN: 4300000 		D: 2025-10-01
FD: 2025-10-01 		4 investors
Grant Latest
2026-02-03
$2.5M
1 investor (Pro only)
Seed Extension 2025-10-01
$4.3M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

F

Faouzi Khechana

CEO

LinkedIn (Pro only)
L

Laurent Massuyeau

Executive Chairman

LinkedIn (Pro only)
N

Nicoletta Sorvillo

CSO

LinkedIn (Pro only)
E

Elodie Dahan

CTO

C

Chris Wiltshire

CBO

View 2 more team members with Pro

Unlock Full Team Directory

Recent News

HemostOD Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology
Company Size
~50 employees (est.)

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro